524 related articles for article (PubMed ID: 9742554)
1. Effects of formulation and process variables on the aggregation of freeze-dried interleukin-6 (IL-6) after lyophilization and on storage.
Lueckel B; Helk B; Bodmer D; Leuenberger H
Pharm Dev Technol; 1998 Aug; 3(3):337-46. PubMed ID: 9742554
[TBL] [Abstract][Full Text] [Related]
2. Formulations of sugars with amino acids or mannitol--influence of concentration ratio on the properties of the freeze-concentrate and the lyophilizate.
Lueckel B; Bodmer D; Helk B; Leuenberger H
Pharm Dev Technol; 1998 Aug; 3(3):325-36. PubMed ID: 9742553
[TBL] [Abstract][Full Text] [Related]
3. Stabilization of IgG1 in spray-dried powders for inhalation.
Schüle S; Schulz-Fademrecht T; Garidel P; Bechtold-Peters K; Frieb W
Eur J Pharm Biopharm; 2008 Aug; 69(3):793-807. PubMed ID: 18477504
[TBL] [Abstract][Full Text] [Related]
4. Impact of fast and conservative freeze-drying on product quality of protein-mannitol-sucrose-glycerol lyophilizates.
Horn J; Schanda J; Friess W
Eur J Pharm Biopharm; 2018 Jun; 127():342-354. PubMed ID: 29522899
[TBL] [Abstract][Full Text] [Related]
5. Freeze-Drying of L-Arginine/Sucrose-Based Protein Formulations, Part 2: Optimization of Formulation Design and Freeze-Drying Process Conditions for an L-Arginine Chloride-Based Protein Formulation System.
Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
J Pharm Sci; 2015 Dec; 104(12):4241-4256. PubMed ID: 26422647
[TBL] [Abstract][Full Text] [Related]
6. Effects of additives on the stability of Humicola lanuginosa lipase during freeze-drying and storage in the dried solid.
Kreilgaard L; Frokjaer S; Flink JM; Randolph TW; Carpenter JF
J Pharm Sci; 1999 Mar; 88(3):281-90. PubMed ID: 10052984
[TBL] [Abstract][Full Text] [Related]
7. Effects of sugar additives on protein stability of recombinant human serum albumin during lyophilization and storage.
Han Y; Jin BS; Lee SB; Sohn Y; Joung JW; Lee JH
Arch Pharm Res; 2007 Sep; 30(9):1124-31. PubMed ID: 17958330
[TBL] [Abstract][Full Text] [Related]
8. A specific molar ratio of stabilizer to protein is required for storage stability of a lyophilized monoclonal antibody.
Cleland JL; Lam X; Kendrick B; Yang J; Yang TH; Overcashier D; Brooks D; Hsu C; Carpenter JF
J Pharm Sci; 2001 Mar; 90(3):310-21. PubMed ID: 11170024
[TBL] [Abstract][Full Text] [Related]
9. Crystallizing amino acids as bulking agents in freeze-drying.
Horn J; Tolardo E; Fissore D; Friess W
Eur J Pharm Biopharm; 2018 Nov; 132():70-82. PubMed ID: 30201570
[TBL] [Abstract][Full Text] [Related]
10. The effects of formulation variables on the stability of freeze-dried human growth hormone.
Pikal MJ; Dellerman KM; Roy ML; Riggin RM
Pharm Res; 1991 Apr; 8(4):427-36. PubMed ID: 1871037
[TBL] [Abstract][Full Text] [Related]
11. Effects of additives on the stability of recombinant human factor XIII during freeze-drying and storage in the dried solid.
Kreilgaard L; Frokjaer S; Flink JM; Randolph TW; Carpenter JF
Arch Biochem Biophys; 1998 Dec; 360(1):121-34. PubMed ID: 9826437
[TBL] [Abstract][Full Text] [Related]
12. Distinct effects of sucrose and trehalose on protein stability during supercritical fluid drying and freeze-drying.
Jovanović N; Bouchard A; Hofland GW; Witkamp GJ; Crommelin DJ; Jiskoot W
Eur J Pharm Sci; 2006 Mar; 27(4):336-45. PubMed ID: 16338123
[TBL] [Abstract][Full Text] [Related]
13. Physical factors affecting the storage stability of freeze-dried interleukin-1 receptor antagonist: glass transition and protein conformation.
Chang BS; Beauvais RM; Dong A; Carpenter JF
Arch Biochem Biophys; 1996 Jul; 331(2):249-58. PubMed ID: 8660705
[TBL] [Abstract][Full Text] [Related]
14. Optimization of storage stability of lyophilized actin using combinations of disaccharides and dextran.
Allison SD; Manning MC; Randolph TW; Middleton K; Davis A; Carpenter JF
J Pharm Sci; 2000 Feb; 89(2):199-214. PubMed ID: 10688749
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the physical stability of freeze-dried sucrose-containing formulations by differential scanning calorimetry.
te Booy MP; de Ruiter RA; de Meere AL
Pharm Res; 1992 Jan; 9(1):109-14. PubMed ID: 1589394
[TBL] [Abstract][Full Text] [Related]
16. Excipients for Room Temperature Stable Freeze-Dried Monoclonal Antibody Formulations.
Haeuser C; Goldbach P; Huwyler J; Friess W; Allmendinger A
J Pharm Sci; 2020 Jan; 109(1):807-817. PubMed ID: 31622600
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the stabilisation of freeze-dried lysozyme and the physical properties of the formulations.
Liao YH; Brown MB; Martin GP
Eur J Pharm Biopharm; 2004 Jul; 58(1):15-24. PubMed ID: 15207533
[TBL] [Abstract][Full Text] [Related]
18. Spray-freeze-drying for protein powder preparation: particle characterization and a case study with trypsinogen stability.
Sonner C; Maa YF; Lee G
J Pharm Sci; 2002 Oct; 91(10):2122-39. PubMed ID: 12226840
[TBL] [Abstract][Full Text] [Related]
19. Impact of dextran on thermal properties, product quality attributes, and monoclonal antibody stability in freeze-dried formulations.
Haeuser C; Goldbach P; Huwyler J; Friess W; Allmendinger A
Eur J Pharm Biopharm; 2020 Feb; 147():45-56. PubMed ID: 31866444
[TBL] [Abstract][Full Text] [Related]
20. The effect of annealing on the stability of amorphous solids: chemical stability of freeze-dried moxalactam.
Abdul-Fattah AM; Dellerman KM; Bogner RH; Pikal MJ
J Pharm Sci; 2007 May; 96(5):1237-50. PubMed ID: 17455341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
